(Q69554461)
Statements
Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPO (English)
M Suzuki
Y Hirasawa
K Hirashima
M Arakawa
M Odaka
Y Ogura
Y Yoshikawa
T Sanaka
A Shinoda
179-92; discussion 212-8